In last trading session, Twist Bioscience Corp (NASDAQ:TWST) saw 0.62 million shares changing hands with its beta currently measuring 2.38. Company’s recent per share price level of $35.17 trading at -$0.68 or -1.90% at ring of the bell on the day assigns it a market valuation of $2.11B. That closing price of TWST’s stock is at a discount of -73.16% from its 52-week high price of $60.90 and is indicating a premium of 22.89% from its 52-week low price of $27.12. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.91 million shares which gives us an average trading volume of 1.10 million if we extend that period to 3-months.
For Twist Bioscience Corp (TWST), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.73. Splitting up the data highlights that, out of 7 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 7 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Twist Bioscience Corp (NASDAQ:TWST) trade information
Twist Bioscience Corp’s shares saw a change of -40.04% in year-to-date performance and have moved -7.52% in past 5-day. Twist Bioscience Corp (NASDAQ:TWST) showed a performance of 3.69% in past 30-days. Number of shares sold short was 10.31 million shares which calculate 8.51 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 50 to the stock, which implies a rise of 29.66% to its current value. Analysts have been projecting 44 as a low price target for the stock while placing it at a high target of 58. It follows that stock’s current price would drop -25.11% in reaching the projected high whereas dropping to the targeted low would mean a loss of -25.11% for stock’s current value.
Twist Bioscience Corp (TWST) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 1.70% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 40.52% while estimates for its earnings growth in next 5 years are of 36.77%.
Twist Bioscience Corp (NASDAQ:TWST)’s Major holders
Insiders are in possession of 1.98% of company’s total shares while institution are holding 114.80 percent of that, with stock having share float percentage of 117.12%. Investors also watch the number of corporate investors in a company very closely, which is 114.80% institutions for Twist Bioscience Corp that are currently holding shares of the company. ARK INVESTMENT MANAGEMENT LLC is the top institutional holder at TWST for having 6.13 million shares of worth $302.06 million. And as of 2024-06-30, it was holding 10.5415 of the company’s outstanding shares.
The second largest institutional holder is ARTISAN PARTNERS LIMITED PARTNERSHIP, which was holding about 6.07 million shares on 2024-06-30. The number of shares represents firm’s hold over 10.4371 of outstanding shares, having a total worth of $299.06 million.
On the other hand, ARK ETF Trust-ARK Innovation ETF and ARK ETF Trust-ARK Genomic Revolution ETF are the top two Mutual Funds which own company’s shares. As of Jun 30, 2025 , the former fund manager was holding 3.72 shares of worth $130.85 million or 6.21% of the total outstanding shares. The later fund manager was in possession of 2.09 shares on Jun 30, 2025 , making its stake of worth around $73.48 million in the company or a holder of 3.49% of company’s stock.
